Fusion Spatial Multiomics Grant Program

Thank you for your interest in this grant program.

Applications are now closed. The grant recipients will be announced soon. Check back here for details.

Grant applications are now closed

Thank you for your interest in the Fusion Spatial Multiomics grant program, sponsored by Akoya Biosciences. Submissions are now closed. Our grant review committee is currently evaluating abstract submissions, due to the high volume of abstracts we received we anticipate that we will announce the grant recipient in early 2023. We appreciate your patience.

About this Grant Program

The Akoya Fusion Spatial Multiomics Grant Program provides oncology researchers an opportunity to explore the power of ultrahigh-plex deep spatial phenotyping with multi-analytes with early access to an ground-breaking new multiomics assay designed for the PhenoCycler-Fusion® platform. The grant recipient will supply up to 3 human tissue samples that will be used to reveal the presence of protein biomarkers and RNA targets of interest on the same platform. They will receive robust spatial mulitomics imaging data on your human tumor tissue samples. With this highly multiplexed, multi-analyte detection approach, you can not only phenotype cells in situ with single-cell resolution, but also investigate the signaling state of these cells by quantifying expression levels of targets difficult to resolve using protein-based methods alone (e.g., chemokines, cytokines, and other secreted proteins).

The grant program is subject to the Fusion Spatial Multiomics Grant Program Terms and Conditions which contain eligibility restrictions. No purchase is necessary to enter; void where prohibited.

Rapid, Unbiased In Situ RNA & Protein Detection

Application deadline: September 30, 2022

Akoya Biosciences invites scientists involved in cancer research to apply for a spatial multiomics grant program that combines the speed and depth of the PhenoCycler™-Fusion System with the power of protein and RNA detection on the same platform.

Through this grant program, you’ll have access to Akoya’s expertise in oncology and broad selection of cancer biomarkers. Ignite your cancer research program with spatial phenotyping fueled by detection of multiple analytes to gain deep insights into the biology of cancers.

The grant recipient will receive:

Deep spatial multiomics data to reveal the presence of relevant RNA and protein markers for the cancer of interest
Spatial insights for up to 3 FFPE tissue samples
An assay report on results of the PhenoCycler-Fusion multiomics workflow

Apply Now for the Fusion Spatial Multiomics Grant Program

For the grant recipient, our team of scientists and bioinformaticians will help to generate a robust spatial phenotyping dataset for up to 3 human samples that will help to elucidate a more comprehensive biological picture of the cancer tissue and model under investigation using spatial phenotyping technology for RNA and protein detection with a broad selection of known cancer biomarkers.

Discover Spatial Multiomics

Get deeper spatial insights cancer with RNA and protein biomarkers for:

Submissions to this grant program will close on September 30, 2022. To apply, complete the registration form with a 300-word abstract describing how obtaining a deep spatial multiomics perspective of your cancer tissue samples at single-cell resolution can support your research project and provide the insights you hope to glean. All the applications will be reviewed by Akoya’s scientific panel to select a grant winner. Selection criteria include, but are not limited to, scientific impact, novelty, feasibility, and the applicability of fast and scalable spatial phenotyping with RNA and protein detection via PhenoCycler-Fusion to your research.